Halit Eren Taskin

Halit Eren Taskin

Auto-generated profile, based on publicly available information

Halit Eren Taskin

Istanbul University-Cerrahpasa, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ZKZehra Kara
Zehra Kara
RARüveyda Akçin
Rüveyda Akçin
ADAhmet Numan Demir
Ahmet Numan Demir
HDHarika Öykü Dinç
Harika Öykü Dinç
HTHalit Eren Taşkın
Halit Eren Taşkın
VYVolkan D. Yumuk
Volkan D. Yumuk


6 January 2021 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
GIGozde In
Gozde In
HTHalit Eren Taskin
Halit Eren Taskin
MAMuzaffer Al
Muzaffer Al
HAHasan Kerem Alptekin
Hasan Kerem Alptekin
KZKagan Zengin
Kagan Zengin
BIBaris Ikitimur
Baris Ikitimur

28 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Maurizio De LucaMaurizio De Luca
Maurizio De Luca
Amanda BelluzziAmanda Belluzzi
Amanda Belluzzi
PSPaulina Salminen
Paulina Salminen
MBMarco Bueter
Marco Bueter
JPJuan Pujol-Rafols
Juan Pujol-Rafols
MMMatteo Monami
Matteo Monami
Background: The prevalence of obesity is already a worldwide health concern. The development of straightforward guidelines regarding the whole available armamentarium (i.e., medical, endoscopic, and surgical interventions in conjunction with a guidance program) is paramount to offering the best multimodal approach to patients with obesity. Methods: The International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) identified a panel of experts to develop the present guidelines. The panel formulated a series of clinical questions (based on the patient, intervention, comparison, and outcome conceptual framework), which have been voted on and approved. A GRADE methodology will be applied to assess the quality of evidence and formulate recommendations employed to minimize selection and information biases. This approach aims to enhance the reliability and validity of recommendations, promoting greater adherence to the best available evidence. Results: These guidelines are intended for adult patients with a body mass index (BMI) ≥ 30 kg/m2 who are candidates for metabolic bariatric surgery (MBS). The expert panel responsible for developing these guidelines comprised 25 panelists (92% were bariatric surgeons) and 3 evidence reviewers, with an average age of 50.1 ± 10.2 years. The panel focused on 3 key questions regarding the combined use of structured lifestyle interventions, approved obesity management medications, and endoscopic weight loss procedures with MBS. Conclusions: The complexity of obesity as a chronic disease requires a comprehensive knowledge of all the available and feasible therapeutic options. The IFSO-EC society felt the urgent need to develop methodologically valid guidelines to give a full picture and awareness of the possible surgical and non-surgical therapeutic strategies employed with a multimodal approach.

7 September 2022 in Obesity Facts
Verified
Journal Article
Open access
PDF file
MAMuzaffer Al
Muzaffer Al
HTHalit Eren Taskin
Halit Eren Taskin
Introduction: This study examined whether 355 obese patients with type 2 diabetes (T2D) of varying duration and severity experienced equivalent weight loss and T2D remission following a newer sleeve gastrectomy (SG) procedure – SG with transit bipartition (SG-TB). Methods: Primary outcomes were changes in body mass index (BMI), total weight loss (TWL), excess BMI loss (EBMIL), A1C, and diabetes medication use through 24 months. Results: Between December 2015 and December 2019, 399 patients who underwent SG-TB reached the 2-year time point. Follow-up was possible in 355 patients (89.0%): 206 females (58.0%), mean age 51.5 years (24.0–73.0), BMI 34.0 kg/m2 (28.0–50.5), and T2D duration 12.0 years (4.0–37.0). At 2 years, total sample respective mean TWL and EBMIL were 20.2 ± 6.1% (95% CI: 19.5, 20.8) and 87.7 ± 35.2% (84.1, 91.4) corresponding to mean BMI change of 7.0 ± 2.7 kg/m2 (6.7, 7.3) (p < 0.001). T2D duration and severity subgroups experienced comparable BMI and A1C change from baseline (p < 0.001); 281 (79.2%) maintained complete remission. ANOVA showed significant mean increases in vitamin D, calcium, and albumin: overall complication rate, 10.2%; no mortality. Discussion/Conclusion: In 355 patients with obesity who underwent SG-TB, excellent weight loss, T2D, and nutritional outcomes were seen at 2-year follow-up regardless of preoperative T2D duration and severity.

11 May 2022 in Obesity Facts
Verified
Journal Article
Open access
PDF file
DYDilek Yazıcı
Dilek Yazıcı
MFMehmet Mahir Fersahoğlu
Mehmet Mahir Fersahoğlu
TFTuba Fersahoğlu
Tuba Fersahoğlu
NBNuriye Esen Bulut
Nuriye Esen Bulut
HÇHüseyin Çiğiltepe
Hüseyin Çiğiltepe
VYVolkan D. Yumuk
Volkan D. Yumuk
Introduction: The coronavirus disease 2019 (COVID-19) pandemic led to a lockdown period. Confinement periods have been related to unhealthy lifestyle behaviors. Our study aimed to determine weight change, changes in eating and exercise habits, the presence of depression and anxiety, and diabetes mellitus (DM) status in a cohort of patients with obesity. Methods: The study was undertaken in nine centers of Collaborative Obesity Management (COM) of the European Association for the Study of Obesity (EASO) in Turkey. An e-survey about weight change, eating habits, physical activity status, DM status, depression, and anxiety was completed by patients. The International Physical Activity Questionnaire (IPAQ) score was used to determine physical activity in terms of metabolic equivalents (METs). A healthy nutrition coefficient was calculated from the different categories of food consumption. The Patient Health Questionnaire (PHQ-9) and General Anxiety Disorder (GAD-7) Questionnaire were used for determining depression and anxiety, respectively. Results: Four hundred twenty-two patients (age 45 ± 12.7 years, W/M = 350/72) were included. The healthy nutrition coefficient before the pandemic was 38.9 ± 6.2 and decreased to 38.1 ± 6.4 during the pandemic (p < 0.001). Two hundred twenty-nine (54.8%) patients gained weight, 54 (12.9%) were weight neutral, and 135 (32.3%) lost weight. Patients in the weight loss group had higher MET scores and higher healthy nutrition coefficients compared with the weight gain and weight-neutral groups (p < 0.001). The PHQ and GAD scores were not different between the groups. Percent weight loss was related to healthy nutrition coefficient (CI: 0.884 [0.821–0.951], p = 0.001) and MET categories (CI: 0.408 [0.222–0.748], p = 0.004). One hundred seventy patients had DM. Considering glycemic control, only 12 (8.4%) had fasting blood glucose <100 mg/dL and 36 (25.2%) had postprandial BG <160 mg/dL. When patients with and without DM were compared in terms of dietary compliance, MET category, weight loss status, PHQ-9 scores, and GAD-7 scores, only MET categories were different; 29 (11.7%) of patients in the nondiabetic group were in the highly active group compared with 5 (2.9%) in the diabetic group. Conclusion: The COVID-19 lockdown resulted in weight gain in about half of our patients, which was related to changes in physical activity and eating habits. Patients with DM who had moderate glycemic control were similar to the general population in terms of weight loss but were less active.